Industry Funding for Continuing Medical Education: Is It Ethical?

Archives of Ophthalmology

Volumn 122, Issue 5, 2004, Pages 771-773

  Heaphy, David P ^a   Marrow, Victor B ^a,b  

^a Johns Hopkins Univ Sch of Medicine ^*

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; EDUCATION PROGRAM; FINANCIAL MANAGEMENT; MEDICAL EDUCATION; MEDICAL SOCIETY; OPHTHALMOLOGY; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES;

HEALTH CARE AND PUBLIC HEALTH;

CONFLICT OF INTEREST; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; ETHICS, PROFESSIONAL; FINANCIAL SUPPORT; HUMANS; OPHTHALMOLOGY; UNITED STATES;

EID: 2342648772     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.5.771     Document Type: Short Survey

References (9)

1. Davis A. Tactic of drug makers is raising questions about use of research. Wall Street Journal. January 7, 2002;Eastern Edition:A1, A6.
2. Naik G, Biotech firms bypass journals to make news. Wall Street Journal. January 28, 2002:B1, B3.
3. Hensly S. Doctors meet with drug makers to discuss industry sales tactics. Wall Street Journal. January 17, 2002:B2.
4. Petersen M. Merck is said to limit perks in marketing to physicians. New York Times. January 18, 2002;Late Edition-Final Correction Section C:1.
5. Birch D, Cohn G. Standing up to industry: as corporations increasingly hold their purse strings, many researchers feel pressed to deliver favorable results. Baltimore Sun. June 26, 2001; Final Edition:1A.
6. Adams C. Doctors on the run can dine 'n' dash in style in New Orleans. Wall Street Journal. May 14, 2001;Eastern Edition:A1, A6.
7. Garth J, Stolberg SG. With quiet unseen ties, drug makers sway debate. New York Times. October 5, 2000;Late Edition-Final Section A:1.
8. Stolberg SG. Study says clinical guide often hides ties of doctors. New York Times. February 6, 2002; Late Edition-Final Section A;17.
9. Relman A. Separating continuing medical education from pharmaceutical marketing. JAMA [serial online]. 2001;285:2009-2012. Available at: http: //jama.ama-assn.org/cgi/content/full/285/15 /2009. Accessed February 18, 2004.